Daniel J. Hicklin
2022
In 2022, Daniel J. Hicklin earned a total compensation of $2.5M as President and Chief Executive Officer at Werewolf Therapeutics, a 1% increase compared to previous year.
Compensation breakdown
| Bonus | $275,278 |
|---|---|
| Option Awards | $1,657,588 |
| Salary | $530,400 |
| Other | $11,630 |
| Total | $2,474,896 |
Hicklin received $1.7M in option awards, accounting for 67% of the total pay in 2022.
Hicklin also received $275.3K in bonus, $530.4K in salary and $11.6K in other compensation.
Rankings
In 2022, Daniel J. Hicklin's compensation ranked 1,473rd out of 5,760 executives tracked by ExecPay. In other words, Hicklin earned more than 74.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,473 out of 5,760 | 74th |
Division Manufacturing | 737 out of 3,136 | 77th |
Major group Chemicals And Allied Products | 287 out of 1,422 | 80th |
Industry group Drugs | 266 out of 1,323 | 80th |
Industry Pharmaceutical Preparations | 189 out of 969 | 81st |
Source: SEC filing on April 27, 2023.
Hicklin's colleagues
We found three more compensation records of executives who worked with Daniel J. Hicklin at Werewolf Therapeutics in 2022.